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Abstract
Background  and  objectives:  Arthroscopy  for  shoulder  disorders  is  associated  with  severe  and
difﬁcult to  control  pain,  postoperatively.  The  addition  of  clonidine  to  local  anesthetics  for
peripheral nerve  block  has  become  increasingly  common,  thanks  to  the  potential  ability  of  this
drug to  reduce  the  mass  of  local  anesthetic  required  and  to  prolonging  analgesia  postoperatively.
The present  study  aimed  to  evaluate  the  success  of  brachial  plexus  block  for  arthroscopic  rotator
cuff surgery  using  local  anesthetic  with  or  without  clonidine.
Method:  53  patients  of  both  genders,  between  18  and  70  years  old,  American  Society  of  Anes-
thesiologists  I  or  II,  who  were  scheduled  to  undergo  arthroscopic  shoulder  surgery  were  selected.
Patients were  then  randomized  into  two  groups.  The  verbal  numerical  pain  scale  and  the  pres-
ence of  motor  block  were  obtained  in  the  post-anesthetic  recovery  room  and  6,  12,  18  and  24  h
postoperatively.
Results: The  association  of  clonidine  (0.15  mg)  to  a  solution  of  0.33%  ropivacaine  (30  mL)  in
brachial plexus  block  for  shoulder  arthroscopy  has  not  diminished  the  visual  numeric  pain  scale
values, nor  the  need  for  opioid  rescue  postoperatively.  There  was  a  lower  incidence  of  nau-
sea/vomiting  postoperatively  and  a  signiﬁcant  motor  block  time  prolongation  in  the  group  of
patients who  received  clonidine  as  adjuvant.
Conclusions:  The  use  of  brachial  plexus  block  with  local  anesthetic  for  analgesic  postoperative
control is  well  established  in  the  literature.  The  addition  of  clonidine  in  the  dose  proposed  for
prolongation  of  the  analgesic  effect  and  reduction  of  opioid  rescue  proved  unhelpful.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
he  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-© 2014  Sociedade  Brasileir
open access  article  under  t
nc-nd/4.0/).∗ Corresponding author.
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Associac¸ão  de  clonidina  e  ropivacaína  no  bloqueio  de  plexo  braquial  para  artroscopia
de  ombro
Resumo
Justiﬁcativa  e  objetivos:  A  artroscopia  para  afecc¸ões  do  ombro  associa-se  a  dor  de  forte  inten-
sidade no  pós-operatório,  de  difícil  manejo.  A  adic¸ão  de  clonidina  ao  anestésico  local  em
bloqueios  periféricos  tornou-se  progressivamente  maior  grac¸as  à  potencial  habilidade  dessa
droga de  reduzir  a  massa  de  anestésicos  locais  necessários  e  prolongar  a  analgesia  no  pós-
operatório.  O  presente  estudo  teve  como  objetivo  avaliar  o  sucesso  do  bloqueio  de  plexo
braquial para  a  cirurgia  artroscópica  de  manguito  rotador  com  o  uso  de  anestésico  local  asso-
ciado ou  não  à  clonidina.
Método:  Foram  selecionados  53  pacientes  de  ambos  os  sexos,  entre  18  e  70  anos,  ASA  I  ou  II,  que
seriam submetidos  à  cirurgia  de  ombro  por  artroscopia.  Os  pacientes  foram  então  randomizados
em dois  grupos.  A  escala  numérica  verbal  de  dor  e  a  presenc¸a  de  bloqueio  motor  eram  obtidas
na sala  de  recuperac¸ão  pós-anestésica  (SRPA)  com  seis,  12,  18  e  24  horas  de  pós-operatório.
Resultados:  A  associac¸ão  de  clonidina  (0,15  mg)  à  soluc¸ão  de  ropivacaína  0,33%  (30  mL)  no
bloqueio de  plexo  braquial  para  artroscopia  de  ombro  não  diminuiu  os  valores  da  escala  visual
numérica de  dor,  nem  a  necessidade  de  resgate  com  opioides  no  pós-operatório.  Houve  uma
menor incidência  de  náuseas  e  vômitos  no  pós-operatório  (NVPO)  e  aumento  considerável  do
tempo de  bloqueio  motor  no  grupo  de  pacientes  que  recebeu  clonidina  como  adjuvante.
Conclusões:  O  uso  do  bloqueio  de  plexo  braquial  com  anestésico  local  para  controle  analgésico
pós-operatório  está  consolidado  na  literatura.  A  adic¸ão  de  clonidina  na  dose  proposta  para
prolongamento  do  efeito  analgésico  e  reduc¸ão  de  resgate  com  opioides  mostrou-se  pouco  útil.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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rachial  plexus  blocks  are  indicated  for  anesthesia  and
nalgesia  in  endoscopic  procedures  of  the  upper  limb,
houlder,  and  clavicle.  This  anesthetic  technique  enables
urgical  procedures  with  short  hospital  stay  (no  overnight
tay)  or  anesthesia  for  procedures  on  an  outpatient  basis,
ith  consequent  cost  reduction.  Its  analgesic  efﬁcacy  and
ow  incidence  of  side  effects  are  important  characteristics.
hen  long  acting  local  anesthetics  are  used,  even  at  a  single
ose,  analgesia  time  ranges  between  10  and  18  h.  Brachial
lexus  block  allows  painless  manipulation  in  physiotherapy,
ften  critical  for  rehabilitation.
Postoperative  pain  is  perhaps  the  main  complication  of
houlder  arthroscopy  involving  the  rotator  cuff.1 The  periph-
ral  nerve  block  can  provide  adequate  analgesia  in  early
ostoperative  period  for  up  to  20  h.2 The  success  of  brachial
lexus  block  depends  on  the  volume  of  anesthetic  used  and
n  the  solution  concentration.  The  concentration  is  the  main
eterminant  of  motor  blockade.3
Clonidine,  an  alpha-agonist  with  partial  action  on  alpha-2
eceptors,  has  been  used  for  years  as  a  centrally  acting  anti-
ypertensive.  Literature  reports  on  the  potential  beneﬁts
f  adding  clonidine  to  local  anesthetics  are  controversial.
he  addition  of  clonidine  to  intermediate  or  long-acting
ocal  anesthetics  for  peripheral  nerve  or  plexus  block  pro-
ongs  the  duration  of  analgesia  and  motor  block  for  about
 h.
The  use  of  this  drug  in  blockades  increased  progressively
ue  to  its  ability  to  reduce  the  mass  of  local  anesthetic
ﬁ
c
r
pequired,  as  well  as  to  prolong  postoperative  analgesia.4
his  potentiating  effect  was  also  seen  when  clonidine  was
dded  to  bupivacaine.5 Parenteral  clonidine,  muscle  or
ntravenously  administered,  did  not  show  the  same  beneﬁt
n  peripheral  nerve  block  compared  with  its  local  use.5 Most
esults  found  for  clonidine  shows  no  adverse  effects,  such
s  hypotension  or  prolonged  sedation  with  its  use  in  regional
lock.6,7 The  combination  of  clonidine  with  bupivacaine,  for
xample,  prolonged  the  analgesic  effect  of  regional  block-
de  for  3--4  h  when  used  in  the  popliteal  fossa  in  foot  and
nkle  surgeries.2
However,  Duma  et  al.8 reported  that  clonidine  added
o  long-acting  local  anesthetic  (bupivacaine  or  levobupiva-
aine)  produced  no  prolonged  analgesic  effect  on  brachial
lexus  block  and  increased  the  variability  of  patient
esponse  to  local  anesthetics,  particularly  to  blockade
atency.  Moreover,  the  optimal  dose  of  clonidine  as  an
djunct  to  blockade  has  not  yet  been  deﬁned.8 Dose
scalation  is  related  to  a  larger  number  of  adverse  effects,
ainly  related  to  the  drug  systemic  absorption.
The  aim  of  this  study  was  to  evaluate  whether  the  addi-
ion  of  clonidine  to  a  local  anesthetic  in  brachial  plexus
lockade  contributed  to  the  quality  of  postoperative  anal-
esia  in  arthroscopic  rotator  cuff  surgery.  We  evaluated
he  visual  numeric  pain  scale  at  the  early  postoperative
eriod,  in  the  post-anesthesia  care  unit  (PACU),  and  at  the
rst  24  h  after  surgery.  We  also  evaluate  the  need  for  res-
ue  analgesia  with  opioids  and  compared  the  incidence  of
esidual  motor  blockade  and  the  length  of  hospital  stay  of
atients.
Clonidine  and  ropivacaine  in  brachial  plexus  block  
Table  1  Anthropometric  data,  gender  distribution,  and
ASA physical  status.
LA  LA  +  Cl  p
Age  (years)  54  ±  10  52  ±  11  0.37
Weight (kg)  77.4  ±  14  78  ±  11  0.89
Sex M  (11),  F  (13)  M  (11),  F  (15)  0.81
ASA I  (8),  II  (16)  I  (9),  II  (17)  0.93
Values are expressed as mean ± SD or absolute values.
LA, local anesthetics; LA + Cl, local anesthetic associated with
clonidine; ASA, American Society of Anesthesiologists.
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nally  enrolled,  49  underwent  interscalene  brachial  plexus
block  and  only  four  patients  underwent  cervical  paraverte-
bral  brachial  plexus  block.  There  was  no  difference  betweenMethod
This  study  was  approved  by  the  Institutional  Ethics  Research
Committee  (HFR-CEP).
Initially,  53  patients  of  both  sexes,  aged  between  18  and
70  years,  classiﬁed  by  the  American  Society  of  Anesthesi-
ologists  (ASA)  as  type  I  or  II,  scheduled  to  undergo  shoulder
arthroscopy  (Table  1)  were  selected.  Patients  were  randomly
allocated  to  two  groups.  The  investigator  responsible  for
postoperative  evaluation  was  blinded  to  group  allocation.
All  patients  signed  an  informed  consent.
Patients  with  cardiac,  respiratory,  liver  or  kidney  disease;
allergy  to  local  anesthetics  and  their  diluents;  neuropathies
or  cognitive  deﬁcits;  body  mass  index  higher  than  45;  and
skin  infection  at  the  site  of  blockade,  or  contralateral
hemidiaphragm  paralysis  were  excluded  from  the  study.
Smoking  was  not  a  criterion  for  selection  of  patients  in  this
study  design.
The  expected  effects  of  using  high  doses  of  clonidine,
such  as  sedation  and  dry  mouth,  were  not  evaluated  in  this
study,  as  patients  were  under  general  anesthesia  immedi-
ately  after  the  blockade.  Possible  cardiovascular  effects  of
alpha-2  agonist  were  also  not  evaluated  because  the  general
anesthesia  maintenance  drugs  (sevoﬂurane  and  sufentanil)
could  be  confounding  factors.
To  calculate  the  sample,  we  consider  a  power  of  90%  and
a  signiﬁcance  level  of  5%,  which  resulted  in  a  sample  size  of
23  patients  per  group.
During  anesthesia,  patients  were  monitored  with  elec-
trocardiogram  (DII,  V5),  pulse  oximetry,  noninvasive  blood
pressure,  capnography,  and  inhaled  gas  analyzer.  Premedi-
cation  was  performed  with  2  mg  intravenous  (IV)  midazolam.
After  brachial  plexus  block,  balanced  general  anesthesia
was  induced  with  the  following  drugs:  propofol  (3  mg  kg−1);
sufentanil  (0.5  g  kg−1);  cisatracurium  (0.15  mg  kg−1);
sevoﬂurane  (1  MAC);  dexamethasone  (10  mg);  ondansetron
(4  mg);  dipyrone  (2000  mg);  ketoprofen  (100  mg);  morphine
(used  only  if  required  for  rescue  analgesia,  50  g  kg−1).
Local  anesthetic  solution  was  diluted  with  1%  ropivacaine
(10  mL)  (Cristália  Laboratório  Farmacêutico)  and  sterile
bidistilled  water  (20  mL),  totaling  a  volume  of  30  mL  to  be
injected.
Postoperatively  on  the  ward,  all  patients  received  a
ﬁxed  dose  of  IV  dipyrone  (2000  mg)  every  6  h.  Morphine
(50  g  kg−1)  was  used  as  rescue  analgesia,  whenever  nec-
essary. t337
rotocol  1:  Effect  of  0.33%  ropivacaine  on
ostoperative  analgesia  in  patients  undergoing
rthroscopic  shoulder  surgery
nitially,  26  patients  were  selected  for  control  group.
rachial  plexus  block  was  performed  with  electrical  nerve
timulator  (Stimuplex  DIG;  BBraun)  and  speciﬁc  needle
Stimuplex  A50,  BBraun).  After  proper  location  of  the  injec-
ion  site,  30  mL  of  0.33%  ropivacaine  solution  was  used.
eneral  anesthesia  was  performed  after  the  blockade.
At  the  end  of  surgery,  presence  of  pain  was  assessed  using
 verbal  numerical  pain  scale  (0:  no  pain,  10:  worst  possible
ain).  During  PACU  stay,  if  there  was  need  for  rescue  with
V  morphine  at  a  dose  greater  than  0.1  mg  kg−1, the  patient
as  excluded  from  the  protocol,  and  plexus  block  failure
as  considered.
Verbal  numerical  pain  scale  and  presence  of  motor  block
ere  obtained  in  PACU  and  at  six,  12,  18,  and  24  h  after
urgery.
rotocol  2:  Effect  of  0.33%  ropivacaine  and
lonidine (0.15  mg)  on  postoperative  analgesia  in
atients undergoing  arthroscopic  shoulder  surgery
nitially,  27  patients  were  selected  for  control  group.
rachial  plexus  blockade  was  performed  with  electrical
erve  stimulator  (Stimuplex  DIG;  BBraun)  and  speciﬁc  nee-
le  (Stimuplex  A50,  BBraun).  After  proper  location  of
he  anesthetic  injection  site,  30  mL  of  0.33%  ropivacaine
olution  and  0.15  mg  of  clonidine  (Cristália  Laboratório  Far-
acêutico)  were  used.  Then,  the  patient  underwent  general
nesthesia.
Verbal  numerical  pain  scale  and  presence  of  motor  block
ere  obtained  in  PACU  and  at  six,  12,  18  and  24  h  after
urgery.
tatistical  analysis
or  continuous  quantitative  variables,  the  values  are  pre-
ented  as  mean  ±  standard  deviation  and  comparisons  were
erformed  using  Student’s  paired  t-test  (normal  variables).
or  ordinal  qualitative  variables,  the  values  are  presented  as
edian  and  interquartile  range,  followed  by  Wilcoxon  test
nonparametric  variables)  (Software  GraphPadPrism  6.0).
he  statistical  signiﬁcance  criterion  was  set  at  p  <  0.05.
esults
n  control  group,  two  patients  were  excluded  from  analy-
is  (one  was  lost  to  postoperative  follow-up,  one  was  later
onsidered  as  ASA  III).  In  clonidine  group,  one  patient  was
xcluded  from  analysis  because  we  considered  that  there
as  a  blockade  failure  (received  morphine  >  0.1  mg  kg−1 in
ACU).
The  anesthesiologist  in  charge  for  the  case  was  free  to
hoose  the  blocking  technique.  Of  the  53  patients  origi-he  two  groups  regarding  techniques  (values  omitted).  There
338  
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aFigure  1  Verbal  rating  pain  scale.
as  no  complication  related  to  the  anesthetic  technique  in
ny  patient  undergoing  the  experimental  protocol.
Brachial  plexus  block  with  0.33%  ropivacaine  (30  mL)
rovided  satisfactory  postoperative  analgesia  to  patients
tudied  at  all  measured  times,  as  shown  in  Fig.  1.  The  visual
nalog  pain  scale  reached  a  median  value  of  two  after  18  h
f  surgery,  which  is  consistent  with  the  half-life  of  ropiva-
aine.  These  values  do  not  differ  from  those  usually  found
n  the  literature  for  this  type  of  procedure.4 Regarding  the
eed  for  morphine  rescue  analgesia,  the  mean  number  of
oses  in  this  group  was  two  (Table  2).  Six  patients  (25%)
ad  postoperative  nausea  and  vomiting  (PONV)  even  after
eceiving  adequate  prophylaxis  with  dexamethasone  and
ndansetron.  The  mean  duration  of  motor  block  in  this  group
fter  surgery  was  1.6  h.  The  mean  hospital  stay  was  20  h.  As
lmost  all  patients  were  discharged  before  the  end  of  the
rotocol,  it  was  continued  by  active  search  through  phone
all  (20  patients  in  control  group  and  22  in  clonidine  group).
In  the  second  group,  brachial  plexus  block  with  0.33%
opivacaine  (30  mL)  combined  with  clonidine  (0.15  mg)  pro-
ided  satisfactory  postoperative  analgesia  to  patients  at  all
easured  times,  as  shown  in  Fig.  1.  The  visual  analog  pain
cale  was  not  statistically  different  from  control  group  at
ny  studied  times.
Regarding  the  need  for  rescue  analgesia  with  morphine,
he  mean  number  of  doses  in  this  group  was  1.1  (Table  2),
lso  with  no  statistical  difference  compared  to  control
Table  2  Number  of  morphine  rescue  doses,  incidence
of PONV,  and  mean  time  of  motor  block  duration  and
hospitalization.
LA  LA  +  Cl  p
Morphine  doses  (50  g  kg−1)  2  ±  2.9  1.1  ±  1.4  0.16
PONV (n)  6  1  0.04
Motor block  (h)  1.6  ±  2.5  7.4  ±  5.2  0.01
Hospitalization  (h)  20.7  ±  6.5  18.8  ±  3  0.24
Values are expressed as mean ± SD.
LA, local anesthetics; LA + Cl, local anesthetic associated with
clonidine; PONV, postoperative nausea and vomiting.
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roup.  Regarding  PONV,  there  was  incidence  in  only  one
atient  (3%)  despite  the  standard  prophylaxis  established.
he  mean  duration  of  residual  motor  blockade  after  the  end
f  surgery  was  7.4  h  (approximately  4.5  times  longer).  The
ean  hospital  stay  was  18.8  h.  A  single  patient  in  this  group
as  hospitalized  for  more  than  one  night,  but  the  reason
as  not  associated  with  anesthesia.
iscussion
he  combination  of  clonidine  (0.15  mg)  to  a  solution  of  0.33%
opivacaine  (30  mL)  in  brachial  plexus  block  for  arthroscopic
houlder  surgery  did  not  decrease  the  values  of  the  visual
umeric  pain  scale  or  the  need  for  postoperative  rescue  with
pioids,  a  result  consistent  with  other  publications  that  used
lonidine,  even  at  doses  higher  than  the  one  used  in  this
tudy.9--11
Adjuvant  drugs  are  aimed  at  prolonging  analgesia,
mprove  quality  or  reduce  the  latency  of  blocks  by  local
nesthetic.  Adrenaline  (in  a  concentration  of  1:400,000--
:200,000),  clonidine  (0.5--1.0  g  kg−1),  or  opioids  (mor-
hine,  sufentanil,  fentanyl,  buprenorphine)  may  be  used,
owever,  with  no  excessive  sedation  or  hypotension.12--14
Clonidine  antinociceptive  mechanisms  are  controversial,
articularly  regarding  synergy  with  local  anesthetics  for
eripheral  blocks,  as  peripheral  nerve  axons  have  no  alpha-2
drenergic  receptors.  Despite  having  originally  been  used  as
n  antihypertensive  and  nasal  decongestant,  clonidine  is  an
lpha-2  adrenergic  agonist  used  as  an  adjuvant  to  local  anes-
hetics,  particularly  in  opioid-dependent  patients.15 Nervous
onduction  delay  or  blockade  through  sodium  channels  may
xplain  the  origin  of  clonidine-induced  antinociception.  The
resence  of  alpha-2  agonists  receptors  in  peripheral  nerves
an  be  decisive  in  analgesic  potentiation,  but  the  results
re  still  controversial.16,17 Other  possible  mechanisms  may
nclude  local  vasoconstrictor  effect  or  analgesic  effects  on
he  central  nervous  system.5 Some  authors  suggest  that
nﬂamed  tissues  are  concomitant  with  increased  sensitivity
f  A-delta  and  C  pain  ﬁbers,  which  is  why  the  addition  of
lonidine  would  be  potentially  beneﬁcial.18
There  is  a  signiﬁcant  interaction  of  clonidine  addition  to
ocal  anesthetics  in  ocular  blocks  (retrobulbar,  peribulbar,
nd  subtenon),  which  leads  to  akinesia  and  prolongation  of
nalgesia.19 Its  analgesic  potentiation  has  been  described
hen  it  was  administered  in  the  intrathecal  and  epidural
pace  (spinal  anesthesia),  particularly  associated  with  short-
cting  local  anesthetics.20
Regarding  the  ideal  drug  combination,  clonidine  appears
o  have  greater  adjuvant  beneﬁt  with  intermediate-acting
ocal  anesthetics,  such  as  lidocaine  and  mepivacaine.  A  sys-
ematic  literature  review  evaluated  27  studies,  of  which
5  had  positive  and  12  negative  results  on  the  addition
f  clonidine.16 It  seems  that  there  are  no  side  effects  at
oses  up  to  0.15  mg.  Moreover,  clonidine  seems  to  be  of
reater  beneﬁt  when  added  to  upper  compared  to  lower
imb  blocks.16
There  is  evidence  in  the  literature  that  favors  the
ddition  of  clonidine  to  reduce  the  latency  of  peripheral
ervous  block  with  ropivacaine  when  this  drug  is  used
or  anesthesia.21 However,  the  results  are  controversial
egarding  prolonged  postoperative  analgesia.  Casati  et  al.7
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reported  that  clonidine  increased  the  analgesic  effect  time
of  ropivacaine  by  20%  after  lower  limb  surgery.
In  our  study,  we  found  a  lower  incidence  of  PONV.  The
smoking  variable  was  not  studied,  a  known  protective  factor
against  PONV,22 which  may  interfere  with  the  results.
Clonidine,  when  given  orally  as  premedication,  was
effective  as  an  adjuvant  drug  to  reduce  PONV  in  ophthalmic
pediatric  surgery.23 Similar  effect  was  also  seen  in  oto-
logic  surgery24 and  to  prevent  postoperative  nausea  and
tremors  of  elderly  patients  undergoing  neuraxial  blocks.25
As  a  single  drug  for  PONV  prophylaxis,  its  effect  is  not  as
evident.26 Clonidine  also  showed  beneﬁt  in  reducing  PONV
when  used  in  the  anesthetic  induction  of  patients  under-
going  mastectomy,27 without  an  increase  of  sedation  or
the  emergence  of  other  signiﬁcant  adverse  effects.  In  the
genesis  of  PONV  appears  to  be  an  adrenergic  autonomic  dys-
function  component,  for  which  reason  the  use  of  clonidine
appear  to  be  beneﬁcial.28
Clonidine  is  a  medication  of  lower  cost  than  the
antiemetic  drugs  acting  through  5-HT3,  such  as  ondansetron
and  its  similar.  However,  we  believe  that  its  real  beneﬁt  as
a  single  drug  for  PONV  prophylaxis  is  small  and  also  that  it  is
not  used  routinely  in  most  anesthesia  services  for  this  pur-
pose.  Furthermore,  this  drug  potential  antiemetic  beneﬁt
can  be  obtained  by  oral  or  venous  administration  without
the  need  to  add  it  to  the  local  anesthetic  solution.
There  was  a  considerable  increase  in  motor  block  dura-
tion  in  patients  receiving  clonidine  as  an  adjuvant.  There  is
evidence  in  the  literature  on  prolongation  of  motor  block
of  bupivacaine  and  mepivacaine  by  alpha-2  agonist.6,29 The
question  to  be  posed  is  about  the  actual  beneﬁt  of  this  pro-
longed  motor  block,  as  the  need  for  rescue  with  opioids  is
not  reduced.  In  our  opinion,  postoperative  prolonged  motor
block  only  increases  patient  anxiety,  without  providing  real
anesthetic  or  surgical  beneﬁt.  This  opinion  is  also  shared  by
other  authors.30 In  selected  cases,  it  may  even  delay  the
recovery  process,  when  we  consider  the  real  possibility  of
early  physiotherapy.
There  was  no  difference  regarding  patient’s  hospital-
ization.  Therefore,  clonidine  did  not  affect  the  procedure
operating  cost.
The  use  of  brachial  plexus  block  with  local  anesthetic
for  postoperative  analgesic  management  is  consolidated  in
the  literature.  However,  the  addition  of  clonidine  at  the
dose  proposed  to  prolong  the  analgesic  effect  and  reduce
the  rescue  with  opioids  in  the  present  study  population
proved  to  be  of  little  beneﬁt  for  brachial  plexus  block  There
are  other  drugs  whose  additive  utility  remains  uncertain
(tramadol,  calcium  channel  blockers,  neostigmine,  dexa-
methasone,  hyaluronidase,  NaHCO3)  and  that  may  be  the
subject  of  future  studies.
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